Harvard Doctor Highlights Matcha’s Potential Cancer-Fighting Benefits

Matcha, a finely ground green tea powder from Japan, is gaining attention for its potential cancer-fighting properties. Dr. Sauarbh Sethi, a Harvard-trained gastroenterologist, highlights its rich catechin content, which may protect cells and inhibit tumor growth. Research from the University of Salford suggests matcha could even enhance chemotherapy effectiveness.

Beyond cancer, matcha is linked to mental performance boosts and mood improvement. A Japanese study found it reduced depression-like symptoms in mice by activating dopamine release. Meanwhile, a Singaporean study showed its compounds could improve targeted cancer drug delivery.

Despite promising findings, experts urge caution, noting conflicting evidence and the need for more rigorous studies. The matcha market continues to grow, with sales exceeding $10 billion in the U.S., driven by health-conscious consumers.

matchacancerantioxidantshealthgreen teanutritionwellnessHarvardresearchlongevity